Regular Periods but Not Ovulating? What a PCOS Cycle Can Hide

Can You Have Regular Periods With PCOS and Still Not Be Ovulating?

Yes: 37% of the women in a population-based study of 1,545 people with self-reported normal-length menstrual cycles turned out to be anovulatory on a single, correctly timed progesterone test, according to a cross-sectional study of more than 3,700 women drawn from a Norwegian public-health survey. None of these women had been referred for a fertility problem or an irregular-cycle complaint — they were sampled at random from the general population, reporting cycles that looked entirely ordinary by any calendar-based definition of “regular.”

That is the distinction this whole page is built on. A period is a surrogate outcome — a stand-in that usually, but not always, tracks the thing actually worth knowing. Ovulation is the real outcome: the release of a mature egg, followed by a corpus luteum producing progesterone. Most months the two are tightly linked, which is exactly why “I have regular periods” gets treated as proof of ovulation by so many people, sometimes including a first intake form. The Norwegian data says that link breaks often enough, even outside PCOS, that “regular” and “ovulatory” cannot be used as synonyms.

Note: in May 2026, PCOS was renamed polyendocrine metabolic ovarian syndrome, or PMOS, by a global consensus of more than 50 organisations. Same condition, same mechanism — only the label changed. This article uses PCOS, since that is still the term most readers search.

Why Does a Bleed Happen at All if No Egg Was Released?

A true, ovulatory period completes a fairly fixed 10–14-day luteal phase, driven by a corpus luteum secreting progesterone on a schedule; an anovulatory bleed follows no such structure, even though it can still land on a normal-looking day count. Two different hormonal events can trigger the uterine lining to shed, and from the outside — similar timing, similar flow, similar cramping — they can look identical. A true period is a progesterone-withdrawal bleed: ovulation happens, the resulting corpus luteum produces progesterone for roughly two weeks, and bleeding starts once that progesterone drops. An anovulatory bleed is an oestrogen-breakthrough bleed instead: a follicle grows and produces oestrogen, then stalls or regresses without ever releasing an egg, and the shift in oestrogen alone is enough to trigger shedding — on a schedule that can, by coincidence, repeat itself cycle after cycle.

Nothing about this mechanism is unique to PCOS — the general-population data above proves that on its own. What PCOS adds is a specific reason the follicle-stalls-without-releasing pattern happens more often: chronically elevated LH and androgen levels disrupt the final maturation step a follicle needs to complete — the same pattern behind why ovulation predictor kits mislead in PCOS. The bleed that follows can still land on a perfectly normal-looking schedule.

How Often Does a “Regular Cycle” Turn Out to Be Anovulatory in a PCOS-Relevant Population?

Forty percent of hirsute women who reported having regular cycles were actually oligo-ovulatory or anovulatory once tested, in a University of Alabama study of 132 consecutive women seen for a hirsutism complaint. Of the 132, 68 already reported cycles longer than 35 days and were excluded from the “regular” group outright. Of the 64 who remained — all self-reporting cycles under 35 days — 25 were found to be oligo-ovulatory or anovulatory on basal body temperature and a day-22–24 progesterone level. Hirsutism is not the same diagnosis as PCOS, but excess androgen is one of PCOS’s defining features, and this is the closest primary data connecting a self-reported “regular cycle” to an objectively measured hormonal outcome in a population that heavily overlaps with it.

That 40% figure sits far above a third estimate worth knowing: only 3.7% of eumenorrheic women had an apparently anovulatory cycle in a database of 550 couples seeking pregnancy, 410 of whom reported regular cycles, and the study’s own authors found most of those 15 low readings had an innocent explanation on closer inspection — an isolated long cycle, a blood draw taken on the wrong day, or perimenopausal timing — leaving only three women, 0.7% of the group, with a consistently low result. Three studies, three very different numbers, and the gap between them is itself informative.

None of these three studies enrolled a group specifically diagnosed with PCOS by Rotterdam criteria — worth stating plainly rather than rounding the numbers into a single PCOS statistic. What they show together is that the rate depends heavily on who is being tested and how strictly “anovulatory” is defined: a random population sample, a group selected for a hyperandrogenic symptom, and a group already actively trying to conceive are three different starting points, and the gap between 3.7% and 40% reflects that difference in population, not a contradiction in the underlying biology.

Phenotype matters here too. The hyperandrogenic PCOS phenotypes — where excess androgen accompanies infrequent or absent ovulation — are the pattern the hirsutism data above actually reflects. A PCOS phenotype built on polycystic ovarian morphology without hyperandrogenism, where ovulation is otherwise well documented, is a different starting point, and nothing above should be read as applying evenly across every phenotype under the same diagnostic umbrella.

Does an Anovulatory Bleed Still Protect the Uterine Lining?

A progesterone-driven period completes its 10–14-day luteal phase and then resets a lining progesterone had already organised; an anovulatory bleed skips that step entirely, and the tissue it sheds was never brought under progesterone’s control in the first place. The 2023 international PCOS guideline names anovulation itself, not cycle spacing, as the mechanism behind the unopposed-oestrogen exposure that drives elevated endometrial risk — which means a bleed landing on schedule does not, on its own, rule that mechanism out.

This is not a reason for alarm over one anovulatory month sitting inside an otherwise regular pattern. The absolute numbers, what actually raises them further, and exactly how much risk stacks up are covered in full on the endometrial hyperplasia risk page, and that risk is driven overwhelmingly by long, unbroken stretches without a genuine shed — the classic oligomenorrhoea and amenorrhoea picture — not by an occasional anovulatory cycle inside a normal-length pattern. What matters practically here is narrower: “my bleed came on day 29, like it always does” answers a scheduling question, not a hormonal one, and it is the hormonal question a clinician needs once bleeding pattern, heaviness, or duration actually changes.

What Does This Mean for Someone Trying to Conceive?

In a cycle that produces a bleed but not an egg, pregnancy cannot occur that month — and if 37% of “regular” cycles in the population study above were exactly this kind of cycle, timing conception attempts off the bleed alone risks missing more fertile windows than it catches. Counting “regular periods” as a green light and stopping there is precisely the assumption the numbers above argue against. Realistic year-over-year conception odds, rather than one cycle at a time, sit in the full picture of getting pregnant with PCOS, and getting the ovulation question right first is what makes those broader numbers apply to an individual case rather than to a population average. This single-cycle question is one piece of the larger PCOS fertility picture, which covers testing, treatment, and timelines beyond any one month’s bleed.

Who This Does Not Apply To

Most regular cycles are still ovulatory — even the population study above found 63% of its participants were, which means “regular but anovulatory” describes a real minority, not the default assumption to make about any one cycle. Anyone using hormonal contraception is a separate case entirely: a withdrawal bleed on the pill, patch, or ring is a response to stopping synthetic hormones, not a report on the ovaries underneath, and none of the reasoning above applies to that bleed one way or the other. And someone who has already confirmed ovulation directly — a correctly timed progesterone test or a clear biphasic BBT pattern across several cycles — does not need to treat every future regular period with suspicion; a pattern established over multiple confirmed cycles is real information, not something a single population study needs to override.

Common questions